줄기세포와 생식세포에서 리프로그래밍 인자에 대한 최근 연구 동향과 전망 = Current Progress and Prospects of Reprogramming Factors - Stem Cells vs Germ Cells -

다국어 초록 (Multilingual Abstract)

Recently induced pluripotent stem (iPS) cells are derived from somatic cells by ectopic expression of several transcription factors (reprogramming factors) using technology of somatic cell reprogramming. iPS cells are able to self- renew and differentiate into all type of cells in the body similarly to embryonic stem cells. Because iPS cells have advantages that can avoid immune rejection after transplantation and ethical issues unlike embryonic stem cells, research on iPS has made significant progress since the first report by Yamanaka in 2006. Nevertheless of many advantages of iPS, safer methods to introduce reprogramming factors into somatic cells must be developed due to safety concerns regarding viral vectors, and safer reprogramming factors to substitute the oncogenes should be evaluated for clinical application of iPS. Here we discuss the recent progress in reprogramming factors in embryonic stem cells, oocytes, and embryos, and discuss further research for finding new, more reliable and safer reprogramming factors.

참고문헌 (Reference)

1 O'Donnell KA, "c-Myc-regulated microRNAs modulate E2F1 expression" 435 : 839-843, 2005

2 Wilmut I, "Viable offspring derived from fetal and adult mammalian cells" 385 : 810-813, 1997

3 Cawley S, "Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs" 116 : 499-509, 2004

4 Hanna J, "Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin" 318 : 1920-1923, 2007

5 Adhikary S, "Transcriptional regulation and transformation by Myc proteins" 6 : 635-645, 2005

6 Chen X, "Transcriptional profiling of Kruppel-like factor 4 reveals a function in cell cycle regulation and epithelial differentiation" 326 : 665-677, 2003

7 Richards M, "The transcriptome profile of human embryonic stem cells as defined by SAGE" 22 : 51-64, 2004

8 Mitsui K, "The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells" 113 : 631-642, 2003

9 Zhang W, "The gut-enriched Kruppel-like factor (Kruppel- like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter" 275 : 18391-18398, 2000

10 Moss EG, "The cold shock domain protein LIN-28 controls developmental timing in C. elegans and is regulated by the lin-4 RNA" 88 : 637-646, 1997

11 Loh YH, "The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells" 38 : 431-440, 2006

12 Yang DH, "Temporally regulated expression of Lin-28 in diverse tissues of the developing mouse" 3 : 719-726, 2003

13 Jaenisch R, "Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming" 132 : 567-582, 2008

14 Viswanathan SR, "Selective blockade of microRNA processing by Lin28" 320 : 97-100, 2008

15 Park IH, "Reprogramming of human somatic cells to pluripotency with defined factors" 451 : 141-146, 2008

16 Niwa H, "Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells" 24 : 372-376, 2000

17 Koscianska E, "Prediction and preliminary validation of oncogene regulation by miRNAs" 8 : 79-92, 2007

18 Masui S, "Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells" 9 : 625-635, 2007

19 Darr H, "Overexpression of NANOG in human ES cells enables feeder-free growth while inducing primitive ectoderm features" 133 : 1193-1201, 2006

20 Koopman P, "Origin and diversity of the SOX transcription factor gene family: genome-wide analysis in Fugu rubripes" 328 : 177-186, 2004

21 Kehler J, "Oct4 is required for primordial germ cell survival" 5 : 1078-1083, 2004

22 Lengner CJ, "Oct4 expression is not required for mouse somatic stem cell self-renewal" 1 : 403-415, 2007

23 Cowan C, "Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells" 309 : 1369-1373, 2005

24 Scholer HR, "New type of POU domain in germ line-specific protein Oct-4" 344 : 435-438, 1990

25 Knoepfler PS, "Myc influences global chromatin structure" 25 : 2723-2734, 2006

26 Li Y, "Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4" 105 : 635-637, 2005

27 Avilion AA, "Multipotent cell lineages in early mouse development depend on SOX2 function" 17 : 126-140, 2003

28 Qiu C, "Lin28- mediated post-transcriptional regulation of Oct4 expression in human embryonic stem cells" 38 : 1240-1248, 2009

29 Cartwright P, "LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism" 132 : 885-896, 2005

30 Segre JA, "Klf4 is a transcription factor required for establishing the barrier function of the skin" 22 : 356-360, 1999

31 Shimozaki K, "Involvement of Oct3/4 in the enhancement of neuronal differentiation of ES cells in neurogenesis-inducing cultures" 130 : 2505-2512, 2003

32 Takahashi K, "Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors" 126 : 663-676, 2006

33 Taranger CK, "Induction of dedifferentiation, genomewide transcriptional programming, and epigenetic reprogramming by extracts of carcinoma and embryonic stem cells" 16 : 5719-5735, 2005

34 Zaehres H, "High-efficiency RNA interference in human embryonic stem cells" 23 : 299-305, 2005

35 Yeom YI, "Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells" 122 : 881-894, 1996

36 Fernandez P, "Genomic targets of the human c-Myc protein" 17 : 1115-1129, 2003

37 Lowry WE, "Generation of human induced pluripotent stem cells from dermal fibroblasts" 2883-2888, 2008

38 Kim D, "Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins" 4 : 472-476, 2009

39 Chambers I, "Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells" 113 : 643-655, 2003

40 Nichols J, "Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4" 95 : 379-391, 1998

41 Suzuki T, "Expression of c-MYC in nuclear speckles during mouse oocyte growth and preimplantation development" 55 : 491-495, 2009

42 Evans MJ, "Establishment in culture of pluripotential cells from mouse embryos" 292 : 154-156, 1981

43 Hinnebusch BF, "Enterocyte differentiation marker intestinal alkaline phosphatase is a target gene of the gut-enriched Kruppel-like factor" 286 : G23-G30, 2004

44 Nagy A, "Embryonic stem cells alone are able to support fetal development in the mouse" 110 : 815-821, 1990

45 Hyslop L, "Downregulation of NANOG induces differentiation of human embryonic stem cells to extraembryonic lineages" 23 : 1035-1043, 2005

46 Ivanova N, "Dissecting self-renewal in stem cells with RNA interference" 442 : 533-538, 2006

47 Maherali N, "Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution" 1 : 55-70, 2007

48 Hough SR, "Differentiation of mouse embryonic stem cells after RNA interference-mediated silencing of OCT4 and Nanog" 24 : 1467-1475, 2006

49 Pesce M, "Differential expression of the Oct-4 transcription factor during mouse germ cell differentiation" 71 : 89-98, 1998

50 Boyer LA, "Core transcriptional regulatory circuitry in human embryonic stem cells" 122 : 947-956, 2005

51 Paria BC, "Antisense c-myc effects on preimplantation mouse embryo development" 10051-10055, 1992

52 Li Z, "A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells" 8164-8169, 2003

53 Li J, "A dominant-negative form of mouse SOX2 induces trophectoderm differentiation and progressive polyploidy in mouse embryonic stem cells" 282 : 19481-19492, 2007

54 Rosner MH, "A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo" 345 : 686-692, 1990